The principal goal of the Education & Information Transfer Core (Core D) of our Alzheimer's Disease Research Center (ADRC) is to communicate information concerning issues related to aging and age-associated disorders, particularly Alzheimer's disease (AD). Using a variety of information transfer vehicles, our program is designed to reach three groups: the lay public, including members of families of affected individuals and other caregivers; medical/graduate students, clinical investigators, and basic scientists; and physicians, nurses, social workers, and other professionals working in the health care field. Outreach programs are designed to communicate with individuals, families, caregivers, lay persons, and local and regional non-academic associations of health professionals and with minority populations We have initiated a newsletter for families, caregivers, and the lay public, and are making a concerted effort to educate minorities in our region concerning AD. To train young clinicians and scientists, we have continued existing programs and have created a formal Neurobiology of Disease Training Program, which was recently funded by the NIH. This grant will provide stipends to trainees, some of whom will work on ADRC projects. The ADRC sponsors a series of lectures, seminars, opportunities for clinical/laboratory rotations and a Visiting Professor Lectureship. At the local, national, and international levels, ADRC clinicians/scientists participate in a broad range of meetings whose focus ranges from clinical issues (diagnosis, therapeutic trials, etc.), to animal models, to cellular/molecular biology. By facilitating the exchange of information, the activities of the ADRC promote public awareness, aid caregivers, health professionals, and encourage new investigators to enter the field of aging and AD. In summary, Core D helps us to realize several goals: to educate the public concerning AD and related disorders; to disseminate new findings from clinical and basic research to the lay, medial, and scientific communities for these individuals to do clinical and/or basic research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005146-17
Application #
6210908
Study Section
Special Emphasis Panel (ZAG1-PCR-3 (J5))
Project Start
1984-09-28
Project End
2004-03-31
Budget Start
Budget End
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Behrens, Stephanie; Rattinger, Gail B; Schwartz, Sarah et al. (2018) Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care. Int Psychogeriatr 30:1499-1507
Habes, Mohamad; Sotiras, Aristeidis; Erus, Guray et al. (2018) White matter lesions: Spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy. Neurology 91:e964-e975
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Peng, Shin-Lei; Chen, Xi; Li, Yang et al. (2018) Age-related changes in cerebrovascular reactivity and their relationship to cognition: A four-year longitudinal study. Neuroimage 174:257-262
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Nicolas, Aude (see original citation for additional authors) (2018) Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97:1268-1283.e6
Bouhrara, Mustapha; Reiter, David A; Bergeron, Christopher M et al. (2018) Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. Alzheimers Dement 14:998-1004
Xiong, Yulan; Neifert, Stewart; Karuppagounder, Senthilkumar S et al. (2018) Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A 115:1635-1640
Wong, Dean F; Comley, Robert A; Kuwabara, Hiroto et al. (2018) Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects. J Nucl Med 59:1869-1876

Showing the most recent 10 out of 830 publications